Gerberding Julie L.
EVP, Chief Patient Officer at MRK; Director at CERNER CORP /MO/
- Sold, on record
- $31.8M
- Dollars the filings state
- Form 4 sales
- 8
- Latest Nov 1, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- MRKMerck & Co., Inc.EVP, Chief Patient Officer
- CERNER CORP /MO/Director
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- MRK404,709 shares
- CERNER CORP /MO/7,928 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale MRKUnusualMay 8, 2015 2015
Sold 38,368 shares at $60.99 ($2.3M)
Gerberding Julie L., EVP Strat Comm, Gl Pub Policy
Sold 54.5% of holdings ($4.3M position)31,985 shares leftFirst sale on recordFiling
- 2 Form 4 sale MRKUnusualNov 7, 2016 +549 days
Sold 85,523 shares at $60.02 ($5.1M)
Gerberding Julie L., EVP Strat Comm, Gl Pub Policy
Sold 68.6% of holdings ($7.5M position)39,115 shares leftFiling
- 3 Form 4 sale MRKPlan not statedMay 15, 2018 +554 days
Sold 9,972 shares at $59.66 ($595k)
Gerberding Julie L., EVP Strat Comm, Gl Pub Policy
Sold 17.9% of holdings ($3.3M position)45,717 shares leftFiling
- 4 Form 4 sale MRKUnusualNov 7, 2018 +176 days
Sold 36,218 shares at $75.14 ($2.7M)
Gerberding Julie L., EVP Strat Comm, Gl Pub Policy
Sold 43.9% of holdings ($6.2M position)46,263 shares leftFiling
- 5 Form 4 sale CERNER CORP /MO/UnusualAug 22, 2019 +288 days
Sold 7,928 shares at $71.82 ($569k)
Gerberding Julie L., Director
Sold 49.4% of holdings ($1.2M position)8,128 shares leftFirst sale on recordFiling
- 6 Form 4 sale MRKUnusualJan 13, 2020 +144 days
Sold 102,073 shares at $89.34 ($9.1M)
Gerberding Julie L., EVP Strat Comm, GI Pub Policy
Sold 73.4% of holdings ($12.4M position)37,038 shares leftFiling
- 7 Form 4 sale MRKUnusualJul 17, 2020 +186 days
Sold 36,285 shares at $80.01 ($2.9M)
Gerberding Julie L., EVP Strat Comm, GI Pub Policy
Sold 57.7% of holdings ($5M position)26,577 shares leftFiling
- 8 Form 4 sale MRKUnusualNov 1, 2021 +472 days
Sold 96,270 shares at $87.91 ($8.5M)
Gerberding Julie L., EVP, Chief Patient Officer
Sold 71.1% of holdings ($11.9M position)39,162 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (8)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 1, 2021 | Nov 3, 2021 | MRK | EVP, Chief Patient Officer | Form 4 sale | 96,270 | $8.5M | 71.1% | Unusual | SEC |
| Jul 17, 2020 | Jul 20, 2020 | MRK | EVP Strat Comm, GI Pub Policy | Form 4 sale | 36,285 | $2.9M | 57.7% | Unusual | SEC |
| Jan 13, 2020 | Jan 15, 2020 | MRK | EVP Strat Comm, GI Pub Policy | Form 4 sale | 102,073 | $9.1M | 73.4% | Unusual | SEC |
| Aug 22, 2019 | Aug 23, 2019 | CERNER CORP /MO/ | Director | Form 4 sale | 7,928 | $569k | 49.4% | Unusual | SEC |
| Nov 7, 2018 | Nov 8, 2018 | MRK | EVP Strat Comm, Gl Pub Policy | Form 4 sale | 36,218 | $2.7M | 43.9% | Unusual | SEC |
| May 15, 2018 | May 16, 2018 | MRK | EVP Strat Comm, Gl Pub Policy | Form 4 sale | 9,972 | $595k | 17.9% | Plan not stated | SEC |
| Nov 7, 2016 | Nov 8, 2016 | MRK | EVP Strat Comm, Gl Pub Policy | Form 4 sale | 85,523 | $5.1M | 68.6% | Unusual | SEC |
| May 8, 2015 | May 11, 2015 | MRK | EVP Strat Comm, Gl Pub Policy | Form 4 sale | 38,368 | $2.3M | 54.5% | Unusual | SEC |